WallStSmart

Aspire BioPharma, Inc. (ASBP)vsGenuine Parts Co (GPC)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Genuine Parts Co generates 25939500% more annual revenue ($25.33B vs $97,660). GPC leads profitability with a 0.1% profit margin vs 0.0%. GPC earns a higher WallStSmart Score of 47/100 (D+).

ASBP

Avoid

22

out of 100

Grade: F

Growth: 4.3Profit: 4.5Value: 5.0Quality: 5.3
Piotroski: 3/9Altman Z: -83.49

GPC

Hold

47

out of 100

Grade: D+

Growth: 4.0Profit: 5.0Value: 2.7Quality: 4.5
Piotroski: 3/9Altman Z: 1.72
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for ASBP.

GPCSignificantly Overvalued (-34.0%)

Margin of Safety

-34.0%

Fair Value

$111.40

Current Price

$121.39

$9.99 premium

UndervaluedFair: $111.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASBP1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

GPC0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

ASBP4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$11.80M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

GPC4 concerns · Avg: 4.0/10
PEG RatioValuation
1.614/10

Expensive relative to growth rate

Revenue GrowthGrowth
4.2%4/10

4.2% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.724/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ASBP

The strongest argument for ASBP centers on Price/Book.

Bull Case : GPC

GPC has a balanced fundamental profile.

Bear Case : ASBP

The primary concerns for ASBP are Revenue Growth, EPS Growth, Market Cap.

Bear Case : GPC

The primary concerns for GPC are PEG Ratio, Revenue Growth, EPS Growth. A P/E of 468.5x leaves little room for execution misses. Thin 0.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

GPC carries more volatility with a beta of 0.68 — expect wider price swings.

GPC is growing revenue faster at 4.2% — sustainability is the question.

GPC generates stronger free cash flow (243M), providing more financial flexibility.

Monitor AUTO PARTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GPC scores higher overall (47/100 vs 22/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Aspire BioPharma, Inc.

CONSUMER CYCLICAL · AUTO PARTS · USA

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company is headquartered in Humacao, Puerto Rico.

Visit Website →

Genuine Parts Co

CONSUMER CYCLICAL · AUTO PARTS · USA

Genuine Parts Company (GPC) is an American service organization engaged in the distribution of automotive replacement parts, industrial replacement parts, office products and electrical/electronic materials.

Visit Website →

Want to dig deeper into these stocks?